Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma

Published:2011-04-05 Issue:3 Volume:34 Page:393-397
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Günaydın Rıza Önder,Kesikli Sacit Altuğ,Kansu Emin,Hoşal Ali Şefik

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.21738/fullpdf

Reference43 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival;Hoffman;Laryngoscope,2006

3. Five-year survival rates and time trends of laryngeal cancer in the US population;Cosetti;Arch Otolaryngol Head Neck Surg,2008

4. Tumour biology: tumour-associated inflammation versus antitumor immunity;Müller-Hübenthal;Anticancer Res,2009

5. Multi-tasking of helper T cells;Wan;Immunology,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proinflammatory cytokines in xeroderma pigmentosum (XP) and non-XP cancer patients—a pilot study;Exploration of Immunology;2024-09-04

2. Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-β1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy;PLOS ONE;2018-08-10

3. Serum cytokine profile of laryngeal squamous cell carcinoma patients;The Journal of Laryngology & Otology;2017-03-15

4. Immune suppression and evasion in patients with head and neck cancer;Advances in Cellular and Molecular Otolaryngology;2013-01

5. Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients;International Journal of Oncology;2011-11-10